Fortis Capital Management’s Lyell Immunopharma LYEL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-605
| Closed | -$6.51K | – | 175 |
|
|
2025
Q1 | $6.51K | Hold |
605
| – | – | ﹤0.01% | 154 |
|
|
2024
Q4 | $7.74K | Hold |
605
| – | – | ﹤0.01% | 133 |
|
|
2024
Q3 | $16.7K | Hold |
605
| – | – | ﹤0.01% | 130 |
|
|
2024
Q2 | $17.5K | Hold |
605
| – | – | ﹤0.01% | 128 |
|
|
2024
Q1 | $27K | Buy |
+605
| New | +$27K | 0.01% | 117 |
|